Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sensors (Basel) ; 24(5)2024 Mar 03.
Artigo em Inglês | MEDLINE | ID: mdl-38475187

RESUMO

Wetlands are amongst Earth's most dynamic and complex ecological resources, serving productive and biodiverse ecosystems. Enhancing the quality of wetland mapping through Earth observation (EO) data is essential for improving effective management and conservation practices. However, the achievement of reliable and accurate wetland mapping faces challenges due to the heterogeneous and fragmented landscape of wetlands, along with spectral similarities among different wetland classes. The present study aims to produce advanced 10 m spatial resolution wetland classification maps for four pilot sites on the Island of Newfoundland in Canada. Employing a comprehensive and multidisciplinary approach, this research leverages the synergistic use of optical, synthetic aperture radar (SAR), and light detection and ranging (LiDAR) data. It focuses on ecological and hydrological interpretation using multi-source and multi-sensor EO data to evaluate their effectiveness in identifying wetland classes. The diverse data sources include Sentinel-1 and -2 satellite imagery, Global Ecosystem Dynamics Investigation (GEDI) LiDAR footprints, the Multi-Error-Removed Improved-Terrain (MERIT) Hydro dataset, and the European ReAnalysis (ERA5) dataset. Elevation data and topographical derivatives, such as slope and aspect, were also included in the analysis. The study evaluates the added value of incorporating these new data sources into wetland mapping. Using the Google Earth Engine (GEE) platform and the Random Forest (RF) model, two main objectives are pursued: (1) integrating the GEDI LiDAR footprint heights with multi-source datasets to generate a 10 m vegetation canopy height (VCH) map and (2) seeking to enhance wetland mapping by utilizing the VCH map as an input predictor. Results highlight the significant role of the VCH variable derived from GEDI samples in enhancing wetland classification accuracy, as it provides a vertical profile of vegetation. Accordingly, VCH reached the highest accuracy with a coefficient of determination (R2) of 0.69, a root-mean-square error (RMSE) of 1.51 m, and a mean absolute error (MAE) of 1.26 m. Leveraging VCH in the classification procedure improved the accuracy, with a maximum overall accuracy of 93.45%, a kappa coefficient of 0.92, and an F1 score of 0.88. This study underscores the importance of multi-source and multi-sensor approaches incorporating diverse EO data to address various factors for effective wetland mapping. The results are expected to benefit future wetland mapping studies.

2.
Sci Rep ; 10(1): 21046, 2020 12 03.
Artigo em Inglês | MEDLINE | ID: mdl-33273636

RESUMO

Proton pump inhibitors (PPIs) are among the most prescribed medications. Previous epidemiological studies have presented contradictory results about PPIs and the risk of dementia. Our objective was to investigate the association between the use of PPIs and an increasing risk of incident AD or non-AD dementias. A community-based retrospective cohort study was conducted based on the data available from 1st January 2002 to 31st December 2015 in the Catalan health service (CatSalut) system. This cohort included all PPI users (N = 36,360) and non-users (N = 99,362). A lag window of 5 years was considered between the beginning of the PPI treatment and the diagnosis of dementia. PPI use was not associated with the risk of AD (adjusted odds ratio (OR) 1.06) (95% CI 0.93-1.21; p = 0.408). A weakly but significantly increased risk of non-AD dementias was observed among PPI users (adjusted OR 1.20, 95% CI 1.05-1.37; p = 0.007). A higher dose of PPIs was not associated with an increased risk of either AD or non-AD dementias (OR 1.20; 95% CI 0.91-1.61 and OR 0.95; 95% CI 0.74-1.22, respectively). Regarding the number of PPIs used, we observed an increased risk of AD (OR 1.47; 95% CI 1.18-1.83) and non-AD dementias (OR 1.38; 95% CI 1.12-1.70) in users of two types of PPIs compared with those who used only one type. We did not find a higher incidence of AD among PPI users, but a weak increase in the risk of non-AD dementias among PPI users was observed.


Assuntos
Doença de Alzheimer/epidemiologia , Transtornos Cognitivos/epidemiologia , Inibidores da Bomba de Prótons/efeitos adversos , Idoso , Uso de Medicamentos/estatística & dados numéricos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Inibidores da Bomba de Prótons/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA